Sat.Oct 07, 2023 - Fri.Oct 13, 2023

article thumbnail

Pharmacists Raise the Alarm About Staffing, Workload

Pharmacy Times

With walkouts across the country and other efforts to raise public awareness, pharmacists are working to find solutions to understaffing and workload challenges.

149
149
article thumbnail

HLTH23: Surescripts analysis finds e-prescribing by pharmacists on the rise

Fierce Healthcare

LAS VEGAS—A new analysis finds that mor | LAS VEGAS—A new analysis finds that more pharmacists are electronically prescribing medications as they assist in managing chronic disease, which offers a peek at the next evolution in primary care.

128
128
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Advocacy, PBM Reform Remain Crucial for Independent Pharmacy Survival

Drug Topics

The National Community Pharmacists Association (NCPA) is leading the way on PBM reform. Ginny Langbehn, vice president of marketing and communications at American Associated Pharmacies (AAP) sat down with B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association (NCPA) and Anne Cassity, JD, NCPA’s senior vice president of government affairs, to discuss challenges in the PBM model, recent state- and federal-level legislative activity to reign in PBM practices, and much more

article thumbnail

Opinion: Yes, everyone should get an updated Covid-19 vaccine

STAT

Last month, the Centers for Disease Control and Prevention recommended that everyone in the U.S. 6 months and older receive an updated Covid vaccine targeting the XBB.1.5 variant. Since then, some notable voices, including Paul Offit , have publicly questioned whether the updated vaccine is needed for those who are not in a high-risk group. He recently wrote, “At this point in the pandemic, it is hard to make a case for vaccinating everyone.

Vaccines 145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Approves Encorafenib Plus Binimetinib Combination for Non-Small Cell Lung Cancer

Pharmacy Times

Encorafenib (Braftovi; Pfizer Inc) and binimetinib (Mektovi; Pfizer Inc) approved for the treatment of patients with metastatic non-small cell lung cancer who harbor a BRAF V600E mutation.

FDA 139
article thumbnail

HLTH23: Experts debate the flaws, future of Medicare Advantage

Fierce Healthcare

LAS VEGAS—Medicare Advantage (MA) has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder. | LAS VEGAS—Medicare Advantage has only grown over the last decade, and, in tandem, voices criticizing the program have gotten louder.

140
140

More Trending

article thumbnail

STAT+: Like a vampire, some cancer cells can suck the energy source from immune cells

STAT

As elite hunters of the immune system, T cells are constantly prowling our bodies for diseased cells to attack. But when they encounter a tumor, something unexpected can happen. New research shows that some cancer cells can fire a long nanotube projection into the T cell that, like a vampire’s fang, sucks energy-creating mitochondria from the immune cell, turning the predator into prey.

article thumbnail

Expert: The Impact Pharmacists Provide to Expanded Scope and Care to Patients

Pharmacy Times

Cheri Schmit, RPh, Senior Manager of clinical Solutions at Cardinal Health, discusses the role of the pharmacists, how the pharmacy profession has changed, and what is to come in the field.

132
132
article thumbnail

Why One Medical's CMO believes Amazon Health can make a big impact tackling chronic diseases

Fierce Healthcare

Amazon’s $3.9 billion acquisition of One Medical made big waves when it was announced in July 2022, signaling that the online retailer had bold ambitions to expand its reach in healthcare. | One Medical CMO Dr. Andrew Diamond is bullish about what Amazon is building in healthcare. He believes Amazon Health can help tackle the burden of chronic diseases in the U.S.

138
138
article thumbnail

JAK Inhibitors May Increase Risk of Shingles in Patients With Immune-Mediated Inflammatory Diseases

Drug Topics

Patients with rheumatoid arthritis had a higher risk of shingles when treated once a day with 4 mg of baricitinib, 100 mg of peficitinib, or 30 mg of upadacitinib.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Treating Rural America: The new country doctors

STAT

Family medicine physician Olusunmisola Oyesiku always thought she would practice in a big city, but after going through her family residency program at the University of Alabama in Selma, she ended up falling in love with rural medicine. The Selma program is one of a small, but growing, number of residencies in the country that places residents entirely in rural medical settings.

article thumbnail

Use of Antidepressants in Older Adults Linked to Driving Impairment on a Road Test

Pharmacy Times

Use of antidepressants and other classes of prescription drugs can increase the risk of driving impairment compared to nonuse, so clinicians and pharmacists should review these risks with older adults.

132
132
article thumbnail

Employer plans are unsuitable for many Americans, survey finds

Fierce Healthcare

Four in 10 people insured by employer-provided health plans find their out-of-pocket costs are so expensive they need to dip into savings and take on debt, according to a nationwide survey of 2,500 | A new survey revealed that nearly half of respondents said they would struggle to afford a medical emergency.

Insurance 138
article thumbnail

Preventing Severe Respiratory Infections in Children

Drug Topics

A refresher on best interventions for common respiratory disorders in children.

187
187
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The ‘abortion queen’ wants patients to have ‘skin in the game.’ Is that restricting access?

STAT

BRISTOL, Va. — Stephanie Rosenwinge was excited to work for the queen of abortion. She’d grown up in rural Virginia with an abusive, alcoholic father. Her mother had had an abortion in 1973, and it may have saved her life: As Rosenwinge put it, “My dad was determined to beat the baby out of her.” Rosenwinge herself had been sexually assaulted while serving in the Gulf War, and she was glad she would’ve had a constitutional right to terminate had the attack resu

145
145
article thumbnail

Pharmacy Focus: Student Edition - Accelerating Success: Western University of Health Sciences' 3.5-Year Program

Pharmacy Times

Tune in to this episode of Pharmacy Focus: Student Edition to discover how innovative programs like Western University's 3.5-year pharmacy program are shaping the future of pharmacy education.

132
132
article thumbnail

Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond

Fierce Pharma

Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers. | Following similar initiatives to bolster mRNA vaccine production and access in Africa, the Bill & Melinda Gates Foundation is providing new funding to a clutch of drugmakers.

Vaccines 138
article thumbnail

Supply chain, email attacks against healthcare groups frequently threatening patient care, report finds

Fierce Healthcare

Supply chain and business email compromise (BEC) attacks against healthcare organizations are among the leading threats to patients’ care and outcomes, according to a new survey report from cyberse | A newly published industry survey also found that IT executives were less concerned about ransomware vulnerability despite an uptick in organizations experiencing such an attack within the past year.

article thumbnail

STAT+: In major test for eGenesis, gene-edited pig kidneys kept monkeys alive for more than two years

STAT

Scientists at a Massachusetts-based biotechnology company and their academic research partners reported Wednesday that an engineered breed of miniature pig containing up to 69 genetic changes produced kidneys that functioned well in monkeys for an average of 176 days and in one animal for more than two years. The results, published in Nature , are an encouraging sign that the long-struggling science of xenotransplantation might one day become a medical reality.

Hospitals 145
article thumbnail

The Community Pharmacy Can Leverage Trust To Improve Health Equity Outcomes

Pharmacy Times

Community pharmacies are ideal locations to identify and recruit underrepresented patients for clinical trials.

article thumbnail

Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears

Fierce Pharma

What doctors described as a “messy” treatment landscape in early-stage non-small cell lung cancer (NSCLC) could get clearer thanks to a first-in-class overall survival win from Merck & Co.’s Ke | What doctors described as a “messy” treatment landscape in early-stage non-small cell lung cancer could get clearer thanks to a first-in-class overall survival win from Merck & Co.’s Keytruda.

FDA 132
article thumbnail

HLTH23: Walmart takes virtual primary care nationwide for its employees

Fierce Healthcare

LAS VEGAS — The team at retail giant Walmart didn't realize how fortuitous a virtual primary care pilot would prove to be when it launched in January of 2020. | LAS VEGAS — The team at retail giant Walmart didn't realize how fortuitous a virtual primary care pilot would prove to be when it launched in January of 2020.

133
133
article thumbnail

The ‘model-eat-model world’ of clinical AI: How predictive power becomes a pitfall

STAT

A growing number of AI tools are being used to predict everything from sepsis to strokes, with the hope of accelerating the delivery of life-saving care. But over time, new research suggests, these predictive models can become a victim of their own success — sending their performance into a nosedive and generating inaccurate, potentially harmful results.

144
144
article thumbnail

Study: Antibiotic Exposure During Pregnancy Associated With Increased Risk of Childhood Respiratory Allergies

Pharmacy Times

The study authors note that it is important for expectant mothers to use antibiotics appropriately and when necessary, as well as monitor their child after birth.

101
101
article thumbnail

Bayer christens $250M cell therapy 'launch facility' in Berkeley

Fierce Pharma

Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. | Despite the promise of cell therapies, manufacturing the personalized medicines at scale has been a limiting factor for many companies. Now, as BlueRock Therapeutics advances its lead prospect, its parent company Bayer is ready to kick production into high gear.

130
130
article thumbnail

HLTH23: Google Cloud rolls out new generative AI search tools for doctors, life sciences companies

Fierce Healthcare

LAS VEGAS—Google's cloud division unveiled new artificial intelligence-powered search capabilities to help doctors and nurses quickly access patients' clinical notes and other medical information a | Google's cloud division unveiled new artificial intelligence-powered search capabilities to help doctors and nurses quickly access patients' clinical notes and other medical information across different data sources.

133
133
article thumbnail

To protect chickens from bird flu, researchers try to CRISPR in immunity

STAT

LONDON — In this case, it was neither the chicken nor the egg that came first. Rather, it started with some specially engineered cells in a lab. The chicken cells had had their genomes edited, not to correct a faulty mutation, but in an effort to blunt the bird flu virus. The chickens that were bred from those cells were designed to be resistant to the infection.

article thumbnail

Uptake, Acceptability of HIV Pre-Exposure Prophylaxis Treatment Influenced by Knowledge, Perception of Risk in MSM

Pharmacy Times

Although increased knowledge and understanding could increase uptake and acceptability of pre-exposure prophylaxis for HIV, action is needed to remove barriers and improve accessibility.

123
123
article thumbnail

Novo Nordisk's unstoppable semaglutide clears kidney disease trial early on positive efficacy

Fierce Pharma

For a study weighing the injectable semaglutide in chronic kidney disease, an early end appears to give Novo Nordisk cause to celebrate. | For a study weighing the injectable semaglutide in chronic kidney disease, an early end appears to give Novo Nordisk cause to celebrate.

129
129
article thumbnail

HLTH23: Clear partners with Verato, b.well to 'ditch the clipboard' and scale up digital identity tech in healthcare

Fierce Healthcare

LAS VEGAS—Despite all the digital innovation in healthcare, a visit to the doctor's office often entails filling out forms on a clipboard and repetitive paperwork. | Despite all the digital innovation in healthcare, a visit to the doctor's office often entails filling out forms on a clipboard and repetitive paperwork. Clear, a company well recognized for its biometric identity verification used in airports, wants to fix these pain points.

131
131
article thumbnail

‘What I’m most proud of’: Nick Jonas talks about managing diabetes, his career, and building community

STAT

LAS VEGAS – Nick Jonas is a global superstar behind electrifying earworms like “Jealous,” “Chains,” and “Sucker,” one-third of the illustrious band The Jonas Brothers — and also a person who lives with type 1 diabetes. He took time out of his world tour to sit down with STAT’s Nicholas St.

141
141
article thumbnail

Esketamine in Combination with Oral Antidepressant Could Aid Treatment-Resistant Depression

Pharmacy Times

Individuals treated with esketamine were more likely to reach remission and remain relapse-free at 8 weeks of treatment.

153
153
article thumbnail

Amylyx's ALS drug Albrioza rebuffed by EU regulator—again

Fierce Pharma

Even as Amylyx’s ALS drug gains steam in the U.S. after a long-awaited FDA approval, the company is struggling with regulatory hurdles overseas. | Europe's drug regulator wasn't swayed by Amylyx's phase 2 data. The European Commission will make the final call on the drug's approval in the bloc by the end of the year.

FDA 126
article thumbnail

UnitedHealth posts $5.8B in profit, $92.4B in revenue on Q3 beat

Fierce Healthcare

UnitedHealth Group kicked off another round of quarterly earnings calls Friday morning, when it reported $5.8 billion in profit for the third quarter. | UnitedHealth Group kicked off another round of quarterly earnings calls on Friday morning, where it reported $5.8 billion in profit for the third quarter.

129
129